Tag: Cancer: Colon

Survival advantage greatest for diagnosis at age 35 through 39 years with stage I or II disease versus diagnosis at age 51 to 55 years

Risk for CRC-related mortality reduced with screening endoscopy for those older than 75 years who do not have significant comorbidities

Link between family history of polyps and CRC risk strengthened with increasing number of relatives and lower age at polyp diagnosis

USPSTF concludes with moderate certainty that CRC screening has moderate net benefit for those aged 45 to 49 years

Risk for EO-CRC increased with each serving per day during adulthood and during adolescence at ages 13 to 18 years

Sequencing results from universal panel changed cancer treatment for roughly one in 10 colorectal cancer patients

Multitarget stool DNA test, fecal immunochemical test, or guaiac-based fecal occult blood test preferred over colonoscopy

Adding machine learning-based image analysis allows noninvasive differentiation of benign and premalignant polyps

Review of meta-analyses of prospective observational studies reveals lower risk with higher intakes of dietary fiber, dietary calcium, yogurt

Screening rates improved in patients due for testing at a community health center predominantly serving people of color